LATEST

Valeant offers discounts on heart drugs
Valeant offers discounts on heart drugsAfter heavy criticism by Congress, presidential candidates and others, Valeant Pharmaceuticals is offering a discount program on its heart drugs Nitropress and Isuprel.
How Vermont aims to cut drug spendingIf a proposed Vermont bill is successful, drug companies would have to explain why they hiked prices on certain drugs.
FDA warns about Cipro, other antibacterialsFDA issued a new warning about potentially serious side effects associated with fluoroquinolone antibacterial drugs. Affected brands include Cipro, Levaquin, Avelox, Factive and Moxaflaxacin injection, as well as the generic Ofloxacin.
Antipsychotic can cause serious reaction: FDAFDA is warning that the antipsychotic medicine olanzapine can cause a rare but serious skin reaction that can progress to affect other parts of the body.
Top 5 facts about new cancer drugFDA recently fast-tracked approval of cabozantinib (Cabometyx, Exelixis, Inc.) to treat advanced renal cell carcinoma. Here are the top 5 facts to know about Cabometyx.
PBM expands pay for value to RA drugsExpress Scripts will implement more programs that pay for drugs based on their effectiveness, according to the PBM’s chief medical officer Steve Miller, MD. Simultaneously, the PBM plans to implement a spending cap on diabetes medications.
First drug approved for hallucinations in Parkinson’sFDA approved the first drug to hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease.
First Zika test on marketThe first US test for the Zika virus is available after Quest Diagnostics received an Emergency Use Authorization (EUA) for its Zika Virus RNA Qualitative Real-Time RT-PCR test (Zika RT-PCR test).
FDA warns about Diflucan during pregnancy
FDA approves new indication for GilotrifFDA recently approved a new indication for afatinib (Gilotrif, Boehringer Ingelheim) for patients with squamous cell carcinoma of the lung. The once-daily tablets are now indicated for the treatment of patients with the lung cancer, whose disease has progressed after treatment with platinum-based chemotherapy. Here are the top 6 facts to know about Gilotrif.

Poll

View Results